U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30 books (147 items)

  • Quoted phrase not found.
  • See the search details.
1.
PDQ Cancer Information Summaries [Internet].

PDQ Cancer Information Summaries [Internet].

Bethesda (MD): National Cancer Institute (US); 2002-.

Table of Contents

2.
Pancreatic cancer in adults: diagnosis and management.

Pancreatic cancer in adults: diagnosis and management.

National Guideline Alliance (UK).

London: National Institute for Health and Care Excellence (NICE); 2018 Feb. (NICE Guideline, No. 85.)

Table of Contents

3.
Addendum to Clinical Guideline 164, Familial breast cancer.

Addendum to Clinical Guideline 164, Familial breast cancer.

London: National Institute for Health and Care Excellence (NICE); 2017 Mar. (Clinical Guideline Addendum, No. 164.1.)

Table of Contents

4.
WHO Guidelines for Indoor Air Quality: Selected Pollutants.

WHO Guidelines for Indoor Air Quality: Selected Pollutants.

Geneva: World Health Organization; 2010.

Table of Contents

5.
Suspected cancer: recognition and referral.

Suspected cancer: recognition and referral.

London: National Institute for Health and Care Excellence (NICE); 2023 Oct 24. (NICE Guideline, No. 12.)

Table of Contents

6.
Cirrhosis in Over 16s: Assessment and Management.

Cirrhosis in Over 16s: Assessment and Management.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2016 Jul. (NICE Guideline, No. 50.)

Table of Contents

7.
Pancreatitis.

Pancreatitis.

London: National Institute for Health and Care Excellence (NICE); 2020 Dec 16. (NICE Guideline, No. 104.)

Table of Contents

8.
Guidelines for the treatment of human African trypanosomiasis [Internet].

Guidelines for the treatment of human African trypanosomiasis [Internet].

Geneva: World Health Organization; 2024 Jun.

Table of Contents

9.
Type 1 diabetes in adults: diagnosis and management.

Type 1 diabetes in adults: diagnosis and management.

London: National Institute for Health and Care Excellence (NICE); 2022 Aug 17. (NICE Guideline, No. 17.)

Table of Contents

10.
Insulin Icodec (Awiqli): CADTH Reimbursement Recommendation: Indication: For the once-weekly treatment of adults with diabetes mellitus to improve glycemic control [Internet].

Insulin Icodec (Awiqli): CADTH Reimbursement Recommendation: Indication: For the once-weekly treatment of adults with diabetes mellitus to improve glycemic control [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jun.

Table of Contents

11.
Management of Type 2 Diabetes Mellitus [Internet].

Management of Type 2 Diabetes Mellitus [Internet].

Richardson CR, Borgeson JR, Van Harrison R, et al.

Ann Arbor (MI): Michigan Medicine University of Michigan; 2021 Oct.

Table of Contents

12.
Obesity Prevention and Management.

Obesity Prevention and Management.

Orringer KA, Van Harrison R, Nichani SS, et al.

Ann Arbor (MI): Michigan Medicine University of Michigan; 2020 Jun.

Table of Contents

13.
Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism.

Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism.

London: National Institute for Health and Care Excellence (NICE); 2019 Aug 13. (NICE Guideline, No. 89.)

Table of Contents

14.
Coeliac Disease: Recognition, Assessment and Management.

Coeliac Disease: Recognition, Assessment and Management.

London: National Institute for Health and Care Excellence (NICE); 2015 Sep. (NICE Guideline, No. 20.)

Table of Contents

15.
Detoxification and Substance Abuse Treatment [Internet].

Detoxification and Substance Abuse Treatment [Internet].

Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2006. (Treatment Improvement Protocol (TIP) Series, No. 45.)

Table of Contents

16.
CADTH Canadian Drug Expert Committee Recommendation: Telotristat Ethyl (Xermelo — Ipsen Biopharmaceuticals Canada Inc): Indication: For the treatment of refractory carcinoid syndrome diarrhea, in combination with somatostatin analogue (SSA) therapy, in patients inadequately controlled by SSA therapy alone [Internet].

CADTH Canadian Drug Expert Committee Recommendation: Telotristat Ethyl (Xermelo — Ipsen Biopharmaceuticals Canada Inc): Indication: For the treatment of refractory carcinoid syndrome diarrhea, in combination with somatostatin analogue (SSA) therapy, in patients inadequately controlled by SSA therapy alone [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jul.

Table of Contents

17.
Genetic Susceptibility to Breast and Ovarian Cancer: Assessment, Counseling and Testing Guidelines.

Genetic Susceptibility to Breast and Ovarian Cancer: Assessment, Counseling and Testing Guidelines.

Bethesda (MD): American College of Medical Genetics; 1999.

Table of Contents

18.
Asciminib (Scemblix): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP) previously treated with 2 or more tyrosine kinase inhibitors [Internet].

Asciminib (Scemblix): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP) previously treated with 2 or more tyrosine kinase inhibitors [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Aug.

Table of Contents

19.
Lutetium (177Lu) Oxodotreotide (Lutathera): CADTH Reimbursement Recommendation: Indication: For the treatment of unresectable or metastatic, well-differentiated, somatostatin receptor (SSR)–positive pancreatic neuroendocrine tumours (pNETs) in adults whose disease has progressed after treatment with a somatostatin analogue (SSA), unless there is a contraindication or intolerance [Internet].

Lutetium (177Lu) Oxodotreotide (Lutathera): CADTH Reimbursement Recommendation: Indication: For the treatment of unresectable or metastatic, well-differentiated, somatostatin receptor (SSR)–positive pancreatic neuroendocrine tumours (pNETs) in adults whose disease has progressed after treatment with a somatostatin analogue (SSA), unless there is a contraindication or intolerance [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Oct.

Table of Contents

20.
Elexacaftor-Tezacaftor-Ivacaftor and Ivacaftor (Trikafta): CADTH Reimbursement Recommendation: Indication: For the treatment of cystic fibrosis in patients aged 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator gene [Internet].

Elexacaftor-Tezacaftor-Ivacaftor and Ivacaftor (Trikafta): CADTH Reimbursement Recommendation: Indication: For the treatment of cystic fibrosis in patients aged 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator gene [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Dec.

Table of Contents

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Search details

See more...

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...